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How adjacent organ fields communicate during de-
velopment is not understood. Here, we identify
a mechanism in which signaling within the forelimb
field restricts the potential of the neighboring heart
field. In zebrafish embryos deficient in retinoic acid
(RA) signaling, the pectoral fins (forelimbs) are lost
while both chambers of the heart are enlarged. We
provide evidence that both of these phenotypes are
due to RA signaling acting directly within the forelimb
field. hoxb5b, an RA-responsive gene expressed
within the forelimb field, is required to restrict the
number of atrial cells arising from the adjacent heart
field, although its function is dispensable for forelimb
formation. Together, these data indicate nonautono-
mous influences downstream of RA signaling that
act to limit individual chamber size. Therefore, our
results offer new perspectives on the mechanisms
regulating organ size and the possible causes of
congenital syndromes affecting both the heart and
forelimb.
INTRODUCTION
The early vertebrate embryo can be thought of as a collage of or-
gan fields, partially overlapping zones of developmental poten-
tial that envelop their respective pools of organ progenitor cells
(Fishman and Chien, 1997; Huxley and deBeer, 1934; Jacobson
and Sater, 1988). Over time, refinement of developmental poten-
tial narrows each field into the precise dimensions of the organ
primordium. The gradual restriction of organ fields is therefore
one important mechanism for controlling organ size. The proxim-
ity and overlap of developing fields suggests that communica-
tion between adjacent territories could contribute to organ field
restriction, but little is known about whether neighboring fields
coordinate their development.
The embryonic heart field is an interesting example of a zone of
developmental potential that becomes restricted over time. Sev-
eral studies have demonstrated that cardiac developmental po-
tential extends beyond the boundaries of the region of the lateral
plate mesoderm (LPM) that normally becomes myocardium. ForDevelopmexample, Notch signaling plays a role in repressing cardiac spec-
ification in a lateral portion of the Xenopus LPM that normally
forms mesocardium and pericardium (Raffin et al., 2000; Rones
et al., 2000). In zebrafish, components of the vascular and hema-
topoietic specification pathways, particularly the transcription
factors Scl and Etsrp, inhibit cardiac specification in rostral
LPM (Schoenebeck et al., 2007). There appear to be multiple
pathways that restrict theplasticity of the heart field, and it is likely
that additional inhibitorymechanisms remain tobecharacterized.
Our recent studies have revealed that the retinoic acid (RA)
signaling pathway plays a potent role in limiting cardiac specifi-
cation. Zebrafish embryos lacking RA signaling exhibit a surplus
of cardiomyocytes, a consequence of an excess of cardiac pro-
genitor cells (Keegan et al., 2005). More recently, it has also been
demonstrated that mouse embryos lacking the RA synthesis en-
zyme Raldh2 display an expansion of the second heart field
(SHF), a territory that contributes to both the inflow and outflow
poles of the amniote heart (Ryckebusch et al., 2008; Sirbu
et al., 2008). It is not yet apparent how this newly identified early
role of RA in restricting the SHF fits together with a previously hy-
pothesized role of RA signaling during cardiac fate assignment in
amniotes. Specifically, it has been proposed that RA signaling
promotes atrial cell identity within the heart field, thereby defining
the relative proportions of atrial and ventricular cells (Hochgreb
et al., 2003; Xavier-Neto et al., 1999, 2001). It remains unknown
whether the proposed roles of RA in promoting atrial identity and
in restricting the SHF are distinct or overlapping. Moreover, it is
unclear where and how RA acts to restrict cardiac specification.
The impact of RA signaling on the forelimb field may provide
clues to the mechanisms by which RA restricts the size of the
heart field. In both zebrafish and mouse embryos that lack RA
signaling, there is a converse relationship between heart and
forelimb formation: forelimbs are lost, while the number of car-
diac cells is increased (Keegan et al., 2005; Niederreither et al.,
1999; Ryckebusch et al., 2008; Sirbu et al., 2008). Previous stud-
ies in both organisms have indicated that RA signaling induces
formation of the forelimb field by promoting tbx5 expression (Be-
gemann et al., 2001; Gibert et al., 2006; Mercader et al., 2006;
Mic et al., 2004). However, it is not known whether this reflects
a direct requirement for RA signaling within forelimb progenitor
cells. It is tempting to speculate about a connection between
the mechanisms that result in forelimb deficiency and cardiac
surplus. One possibility is that reduction of RA signaling converts
forelimb progenitors into heart progenitors, or perhaps effects ofental Cell 15, 923–934, December 9, 2008 ª2008 Elsevier Inc. 923
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natively, RA may impact the development of each field indepen-
dently. The possibility of coordinate regulation of the heart and
forelimb fields is likely to be relevant to the causes of human con-
genital defects that affect both tissues, including inherited heart-
hand syndromes (Wilson, 1998).
In this study, we sought to address where and how RA signal-
ing limits the number of cardiac progenitor cells in zebrafish. We
find that RA signaling restricts the numbers of both atrial and
ventricular cardiomyocytes, through independent effects on
each lineage. Loss of RA signaling leads to a posterior extension
of both atrial and ventricular progenitor cells into territory nor-
mally occupied by forelimb progenitor cells. We show that RA
signaling is required cell-autonomously for forelimb formation.
However, posterior extension of the heart field in embryos lack-
ing RA signaling does not seem to reflect a transformation of
forelimb progenitor cells into cardiac progenitor cells. Addition-
ally, we demonstrate that expression of hoxb5b in the forelimb
field is RA responsive. Strikingly, hoxb5b plays an essential
and nonautonomous role in restricting the number of atrial cardi-
omyocytes that emerge from the heart field. Together, our data
indicate that RA signaling, through its direct effect on forelimb
field formation, acts indirectly to limit the specification of cardiac
progenitors within the heart field; thus, interactions between ad-
jacent organ fields play an important role in the refinement of de-
velopmental potential. These findings provide a new perspective
on the regulation of organ size and may yield insight into the eti-
ology of human heart-hand syndromes.
RESULTS
RA Signaling Restricts the Numbers of Both Atrial
and Ventricular Cells
We have recently demonstrated that RA signaling plays an im-
portant role in restricting the production of cardiac progenitor
cells in the zebrafish embryo (Keegan et al., 2005). However,
this study did not elucidate the mechanisms downstream of
RA signaling that are responsible for heart field restriction. As
a first step toward this goal, we sought to determine whether
RA signaling has comparable effects on both the atrial and ven-
tricular lineages. Therefore, we examined cardiac chamber for-
mation in embryos that were treatedwith either the retinaldehyde
dehydrogenase inhibitor DEAB (Russo et al., 1988) or the RA re-
ceptor antagonist BMS189453 (BMS) (Schulze et al., 2001) be-
ginning at 40% epiboly, just before the onset of gastrulation.
At 48 hr postfertilization (hpf), atrial and ventricular chambers
were distinct and easily identifiable in wild-type embryos
(Figure 1A), aswell as in embryos treatedwith DEAB or BMS (Fig-
ures 1B and 1C). However, the hearts of DEAB-treated or BMS-
treated embryos were highly dysmorphic and typically appeared
enlarged. We counted the cardiomyocytes in each chamber to
determine if aberrant morphology reflected a change in cell num-
ber. Both DEAB and BMS treatments led to a significantly in-
creased number of atrial and ventricular cells (Figures 1D and
1E; see Table S1 available online). Increases in atrial and ventric-
ular populationswere also apparent prior to heart tube formation,
as indicated by the expression patterns of the earliest known
chamber-specific genes, atrial myosin heavy chain (amhc) (Ber-
dougo et al., 2003) and ventricular myosin heavy chain (vmhc)924 Developmental Cell 15, 923–934, December 9, 2008 ª2008 Els(Yelon et al., 1999) (Figures 1F–1K; Table S2). The phenotypes
resulting from treatments with BMS or DEAB resembled those
resulting from treatment with Ro41-5253 (RO, an RARa-specific
antagonist) or from loss of raldh2 gene function (Figures S1 and
S2; Tables S1 and S2; J.S.W. and D.Y., unpublished data). To-
gether, these data show that RA signaling is required to restrict
the numbers of both atrial and ventricular cells in zebrafish.
Reduction of RA Signaling Increases the Numbers
of Atrial and Ventricular Cells through Independent
Mechanisms
To refine our understanding of when RA signaling is required to
limit the numbers of atrial and ventricular cells, we next com-
pared the effects of initiating BMS treatment at different develop-
mental stages. We found a progressive decrease in sensitivity to
BMS over time. Both atrial and ventricular populations are signif-
icantly enhanced when BMS treatment occurs during gastrula-
tion (Figures 1D and 1E; Table S1), similar to our previous find-
ings (Keegan et al., 2005). However, by the 6–8 somite stage,
only atrial cells, not ventricular cells, are affected by BMS treat-
ment (Figures 1D and 1E; Table S1). This temporal difference in
sensitivity to BMS treatment is compatible with the notion that
ventricular differentiation normally precedes atrial differentiation
(Berdougo et al., 2003) and suggests that RA signalingmight limit
atrial and ventricular cell number through different mechanisms.
To determine whether RA signaling has a similar impact on
both atrial and ventricular progenitor specification, we next ex-
amined cardiomyocyte progenitor fate maps from wild-type
and BMS-treated embryos (Figure S3; Table S3). Comparison
of the wild-type and BMS-treated fate maps demonstrated
that BMS treatment does not significantly disrupt the relative
spatial organization of atrial progenitors (APs) and ventricular
progenitors (VPs) (Figures 1L and 1M; Figure S3; Table S3).
Importantly, we did not find VPs in the territory where normally
only APs are found, or vice versa (Figures 1L and 1M;
Figure S3), suggesting that neither increase in cell number oc-
curs at the expense of the other lineage.
To determine whether the increases in ventricular and atrial
cell number in BMS-treated embryos are due to increased num-
bers of VPs and APs, we compared the frequency of encounter-
ing each type of progenitor within their respective territories in
the wild-type and BMS-treated fate maps. We encountered
VPs almost twice as often within the ventricular territory of
BMS-treated embryos as we did within the ventricular territory
of wild-type embryos (p < 0.005; Figures 1L–1N; Figure S3; Table
S3). In contrast, the frequency of encountering APs within the
atrial territory did not change in the BMS-treated fate map (Fig-
ures 1L–1N; Table S3). These data indicate an increase in the
number of VPs in the lateral margin of BMS-treated embryos at
40% epiboly, while the number of APs appears unaffected by
BMS treatment at this stage.
Although BMS treatment did not affect the density of APs at
40% epiboly, we did observe a striking effect of BMS on the
number of labeled progeny produced per AP. Our fate map
data indicated that APs in BMS-treated embryos generated an
increased number of atrial cardiomyocytes compared to wild-
type APs (p < 0.05; Figure 1O; Table S3). In contrast, we did
not observe an increased number of progeny from VPs in
BMS-treated embryos compared to the number of progenyevier Inc.
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map data suggest that RA signaling restricts the number of atrial
cells at a later stage than when it restricts the number of ventric-
ular cells. These data are compatible with the temporal differ-
ences in atrial and ventricular sensitivity to BMS (Figures 1D
and 1E), suggesting different timeframes for independent pro-
cesses of ventricular and atrial specification.
RA-Responsive Genes Are Expressed in the Forelimb
Field
As a next step toward understanding the mechanism through
which RA signaling restricts cardiac chamber size, we wanted
to identify RA-responsive genes that are expressed within the
LPM during the time interval when RA signaling is required to
limit cardiomyocyte production. Although there were some
known targets of RA signaling, their relevance to cardiomyocyte
production was unclear. Using microarrays followed by valida-
tion via in situ hybridization, we identified 12 RA-responsive
genes expressed within the LPM; two examples that were posi-
tively regulated by RA signaling were hoxb5b and retinol short-
chain dehydrogenase/reductase (retSDR1/dhrs3; referred to
here as retd) (Figure 2; Figure S4).
Our identification of RA-responsive genes within the LPM sug-
gested locations of RA signaling that might be related to the role
of RA in restricting cardiac cell number. However, none of these
genes appeared to be expressed within the heart field; instead,
they appeared to be in a more posterior portion of the LPM.
For example, at the 6–8 somite stages, when robust expression
of gata4 and nkx2.5 is first evident in the heart field (Schoene-
beck et al., 2007), retd is found in an adjacent posterior portion
of the LPM (Figures S5D–S5I), and hoxb5b is found at an even
further posterior position (Figures S5J–S5L). This observation
was confirmed by measuring the distances between the poste-
rior and anterior limits of gene expression, relative to the tip of
Figure 1. Reduction of RA Signaling Causes an Increase in the Number of Atrial and Ventricular Cells
(A–C) Frontal views of hearts at 48 hpf expressing the transgene Tg(cmlc2:DsRed2-nuc) (red). Atria are labeled with the anti-Amhc antibody S46 (green). (B and C)
Treatment with 1 mM DEAB or 10 mM BMS causes cardiac chamber enlargement.
(D) Mean and standard deviation (SD) of numbers of atrial and ventricular cardiomyocytes. Stages indicate when DEAB or BMS treatment was initiated. Asterisks
indicate statistically significant differences relative to wild-type (p < 0.005).
(E) Fold difference in mean cell numbers relative to wild-type (WT) controls.
(F–I) Reduction of RA signaling causes increased expression of amhc and vmhc. Dorsal views, anterior to the top at the 20 or 22 somite stage.
(J) Mean and SD of areas of expression of amhc and vmhc in WT and BMS-treated embryos. Asterisks indicate statistically significant differences relative to WT
(p < 0.005).
(K) Fold difference in mean areas of gene expression relative to WT controls.
(L and M) Schematic of 40% epiboly fate maps fromWT and BMS-treated embryos indicating that the relative position of regions containing APs (green) and VPs
(red) is unchanged when RA signaling is reduced. Percentages indicate the frequency of encountering APs or VPs in each region.
(N) Reduction of RA signaling increased the frequency of encountering VPs, but not APs, at 40% epiboly. The asterisk indicates statistically significant difference
relative to WT (p < 0.005).
(O) Reduction of RA signaling increased the mean number of labeled progeny produced by APs but not VPs. The asterisk indicates statistically significant
difference relative to WT (p < 0.05).
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rior limits of gata4 and nkx2.5 expression were on average at 28
and 27 notochord cell diameters (ncds), respectively (Figures 3A
and 3B; Table S4), while the anterior limits of retd and hoxb5b ex-
pression were on average at 36 and 63 ncds, respectively (Fig-
ures 3C and 3D; Table S4). The relatively posterior expression
of RA-responsive genes correlates with the even more posterior
location of raldh2 expression. At these stages, raldh2 is ex-
pressed at high levels in the somites, the most anterior of which
is located on average at 72 ncds (Figure 3E; Figures S5A and
S5B). The distance between raldh2 and gata4 expression in ze-
brafish contrasts with data from mouse and chick embryos
where raldh2 expression is reported to be adjacent to gata4 at
comparable stages (Hochgreb et al., 2003). Although raldh2 be-
gins to be expressedmore anteriorly in the ectoderm in zebrafish
at the 8 somite stage (Figures S5C and S5D; Grandel et al.,
2002), this expression begins at the end of the time period during
which RA signaling is required to limit cardiac cell number (Fig-
ures 1D and 1E). Thus, the locations of RA-responsive genes
and RA synthesis suggest that RA signaling is occurring in a por-
tion of the LPM posterior to the heart field.
We next wanted to understand how the expression patterns of
RA-responsive genes related to the various progenitor popula-
tions present within the LPM. Therefore, we constructed a fate
map of the relevant portion of the LPM at the 8 somite stage in
wild-type embryos (Figure S6), a posterior extension of our prior
fate map of the most anterior portion of the LPM (Schoenebeck
et al., 2007). Our results indicated that the LPM territories con-
taining AP and VP cells extend posteriorly to approximately 50
and 40 ncds, respectively (Figure 3F). Thus, the locations of car-
diac progenitors (CPs) correlate relatively well with the expres-
sion patterns of gata4 and nkx2.5, although theremay be aposte-
rior population of CPs that does not express these genes at this
stage. By comparison, pectoral fin (forelimb) progenitors (FPs)
were found in a territory beginning at approximately 40 ncds
and extending to 60–70 ncds, corresponding to the locations of
retd and hoxb5b expression. Together, our fate map data indi-
cate that RA-responsive genes in the LPM are expressed primar-
ily posterior to the heart field and within the forelimb field.
Loss of RA Signaling Leads to a Posterior Extension
of the Heart Field
Having determined the relative positions of CPs and FPs within
the wild-type LPM, we wanted to examine how loss of RA signal-
ing and the consequential loss of FPs affects the distribution of
CPs. First, we examined LPM gene expression patterns in em-
bryos deficient in RA signaling. We found a significant lengthen-
ing of gata4 expression in the LPM of BMS-treated, DEAB-
treated, and RO-treated embryos (Figures 4A–4D; Table S5). In
all cases, the change in gata4 expression is considerably more
prominent posterior to the notochord tip than it is anterior to
the notochord tip. We also found similar posterior extensions
of nkx2.5 expression in treated embryos (J.S.W. and D.Y., un-
published data). Together, these results suggest that RA signal-
ing restricts the posterior extent of cardiac gene expression
within the LPM.
We were intrigued by this posterior extension of cardiac gene
expression, as it suggested an enlargement of the heart field into
territory that would normally contain the forelimb field. Consis-
tent with this, we detected an altered distribution of tbx5 expres-
sion in RA signaling-deficient embryos (Figures 4E–4H). tbx5 is
expressed in both the heart and forelimb (Ahn et al., 2002; Bege-
mann and Ingham, 2000; Garrity et al., 2002). By the 12–14
somite stage, two slightly separated fields of tbx5 expression ap-
pear to approximate the locations of the CPs and FPs (Figure 4E;
Ahn et al., 2002). In embryos deficient in RA signaling, the sepa-
ration between populations is less evident, suggesting an en-
largement of the anterior population and a reduction or loss of
the posterior population (Figures 4F–4H). These results confirm
and extend the previous observation of a loss of tbx5 expression
in the forelimb field of raldh2 mutant embryos at the 12 somite
stage (Begemann et al., 2001). To examine whether the posterior
extension of cardiac markers corresponds to a posterior exten-
sion of CPs, we constructed LPM fate maps in RA signaling-
deficient embryos. Consistent with our gene expression analy-
sis, the fate map data indicated CPs residing in posterior LPM
territories that are normally occupied by FPs (Figures 3G–3I).
Therefore, our data indicate that RA signaling restricts posterior
extension of the heart field within the LPM.
Loss of RA Signaling Does Not Result in a Fate
Transformation between Cardiac and Forelimb
Progenitors
The posterior expansion of CPs into a region normally occupied
by FPs suggested that a loss of RA signaling may transform FPs
into CPs. One possible scenario, suggested by the expression
patterns of RA-responsive genes, is that cells in the forelimb field
may normally need to receive RA signaling in order to become
Figure 2. RA Signaling Positively Regulates
hoxb5b Expression in the LPM
Expression of hoxb5b at the tailbud (tb) or 8 somite
stages, dorsal views, anterior to the top.
(A–D and F–I) Reduction of RA signaling inhibits
hoxb5b expression, and treatment with RA in-
duces ectopic hoxb5b expression.
(E and J) Expression of the hoxb5b paralog
hoxb5a. Identification of hoxb5b as a RA-respon-
sive gene is not surprising, since the chick and
mouse Hoxb5 orthologs and the zebrafish paralog
hoxb5a have already been implicated as direct tar-
gets of RA signaling (Bruce et al., 2001; Grandel
et al., 2002; Oosterveen et al., 2003; Sharpe
et al., 1998).
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pressed in the Forelimb Field
(A–E) Expression of nkx2.5, gata4, retd, hoxb5b,
and raldh2 relative to ntl, which marks the noto-
chord; dorsal views of flatmounted embryos, ante-
rior to the top, at the 8 somite stage. Brackets and
numbers indicate the mean distance of the limit of
gene expression relative to the tip of the noto-
chord, measured in notochord cell diameters
(ncds). (A and B) The posterior portions of nkx2.5
and gata4 expression overlap with the notochord.
(C) retd expression is found posterior to nkx2.5
and gata4 expression. (D and E) hoxb5b is ex-
pressed closer to raldh2 expression in the so-
mites, a major source of RA in the embryo.
(F) Schematic of the WT LPM fate map at the 8 so-
mite stage, indicating locations of atrial (green, A),
ventricular (red, V), and fin (blue, F) progenitors rel-
ative to the anterior-posterior axis of the noto-
chord, measured in ncds. Numbers in the table
represent the number of labeling experiments in
which each progenitor type was detected at a cer-
tain ncd position; n indicates the total number of
experiments at each position. Experiments were
performed on both the left and right sides of the
embryo; no asymmetries were observed.
(G–I) When RA signaling is reduced, FPs are ab-
sent and CPs frequently occupy FP territory.
(J) In hoxb5bmorphants, FPs are present and CPs
rarely occupy FP territory.FPs rather than CPs. We performed mosaic analysis to deter-
mine whether RA signaling-deficient cells would preferentially
contribute to the heart rather than to the forelimb. We used
two different strategies to deplete RA signal transduction in a
cell-autonomous fashion: transgenic activation of a dominant-
negative RA receptor or BMS treatment (Figure S7). After trans-
planting cells from Tg(hsp70:dnRARa) or BMS-treated donor
embryos into wild-type host embryos, we assessed contribu-
tions of donor cells to the heart and forelimb (Figures 5A–5F).
With either method of autonomously antagonizing RA signaling,
we found a significant decrease in the frequency with which do-
nor cells contribute to the fin mesenchyme (Figures 5G and 5H).
Despite this indication of a cell-autonomous requirement for RA
signaling during fin formation, we did not find a corresponding in-
crease in the frequency of donor cells becoming cardiomyo-
cytes, as would be expected if FPs were transformed into CPs
(Figures 5G and 5H). Therefore, our data suggest that RA signal
transduction is required cell-autonomously to promote FP for-
mation and is most likely acting indirectly to restrict cardiac
cell number.
Hoxb5b Acts Nonautonomously to Restrict Atrial Cell
Number
Having established where RA signaling is acting, we next wanted
to determine if any of the RA-responsive genes expressed in the
forelimb field are required to limit cardiac cell number. Although
anti-retdmorpholinos (MOs) do not appear to affect fin formation
or restrict cardiac cell number (J.S.W. and D.Y., unpublished
data), anti-hoxb5b MOs do seem to disrupt heart formation. To
examine the function of hoxb5b, we usedMOs designed to block
proper splicing of hoxb5b transcripts (Figure 6A). Despite theDevelophigh similarity in target sequences, anti-hoxb5b and anti-hoxb5a
MOs specifically abrogated splicing of their respective tran-
scripts (Figures 6A and 6F). hoxb5b morphants (anti-hoxb5b
MO-injected embryos) exhibit enlarged hearts and pericardial
edema (Figure 6G), reminiscent of embryos with defective RA
signaling. However, hoxb5b morphants have overtly normal
fins (Figure 6H), unlike embryos lacking RA signaling. Although
hoxb5a MOs effectively block splicing and reduce levels
of wild-type hoxb5a transcript (Figure 6A), hoxb5a morphants
resembled wild-type embryos (Figures 6D and 6E). The enlarged
hearts of hoxb5b morphants were especially intriguing
(Figure 6G), so we assessed the number of cells in each cardiac
chamber. Strikingly, hoxb5b morphants contain an increased
number of atrial cells at 48 hpf and an increased number of cells
expressing amhc prior to heart tube assembly (Figures 6I, 6J, 6L–
6O, 6Q, and 6R; Tables S1 and S2). However, neither ventricular
cell number nor vmhc expression is affected in hoxb5b mor-
phants (Figures 6I–6K, 6M–6P, and 6R; Tables S1 and S2). Inter-
estingly, the increases in atrial cell number were similar to those
found in DEAB-treated and RO-treated embryos (Figures 1D and
1E; Figures S2T and S2Y). We therefore wondered whether any
APs are found within the forelimb field of hoxb5b morphants, as
was observed in RA signaling-deficient embryos. Fate mapping
of hoxb5b morphants revealed that atrial cells do occasionally
originate within the forelimb field, although not nearly as fre-
quently as in the fate maps of embryos deficient in RA signaling
(Figures 3G–3J). Consistent with this, we did not observe a pos-
terior expansion of gata4 or nkx2.5 at the 8 somite stage in
hoxb5b morphants (Table S6). This suggests that the majority
of the excess atrial cells in hoxb5b morphants arise from the
heart field.mental Cell 15, 923–934, December 9, 2008 ª2008 Elsevier Inc. 927
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(Figures 3A, 3B, 3D, and 3F; Figures S5J–S5L) strongly sug-
gested that hoxb5b acts through a nonautonomous mechanism
to restrict atrial cell number. We performed two types of mosaic
analysis to test this hypothesis. First, we examined whether
a hoxb5b-deficient environment would affect the contribution
of wild-type cells to the atrium. We transplanted cells from
wild-type donor embryos into hoxb5bmorphant or hoxb5amor-
phant host embryos, the latter of which served as controls (Fig-
ures 7A–7F). We found a 1.5-fold increase in the frequency with
which donor cells contributed to the atrium in hoxb5b morphant
hosts relative to control hoxb5amorphant hosts (Figure 7G), cor-
relating with the 1.5-fold difference in atrial cell number between
hoxb5b morphants and wild-type embryos. We did not detect
a comparable difference in the frequency of donor cells contrib-
uting to the ventricle (Figure 7G). These results suggest that
hoxb5b plays a cell-nonautonomous role in restricting atrial car-
diomyocyte formation.
Next, we testedwhether ectopic sources of hoxb5b, outside of
the heart field, can rescue the atrial cardiomyocyte surplus found
in hoxb5b morphants. In these experiments, we transplanted
cells from donor embryos injected with a hyperactive hoxb5b
(vp16-hoxb5b) mRNA into hoxb5b morphant hosts; transplants
of hoxb5b morphant donor cells into hoxb5b morphant hosts
served as controls (Figures 7H–7K). We then selected chimeras
in which donor cells contributed to anterior mesodermal tissues,
such as the anterior somites, but did not contribute to the heart,
and we assessed cardiac cell number in these embryos. As ex-
pected in the control experiments, donor cells from hoxb5bmor-
phants had no effect on the hoxb5b morphant host phenotype;
just as was seen in hoxb5bmorphants, these chimeras exhibited
a 1.5-fold increase in atrial cell number and no significant change
in ventricular cell number, relative to wild-type (Figures 7L, 7M,
6O, and 6R). In contrast, donor cells expressing hyperactive
hoxb5bmRNA caused a statistically significant (p < 0.05) reduc-
tion of the number of atrial cells in hoxb5b morphant hosts (Fig-
ures 7L and 7M; Table S1). Thus, we find that expression of
hoxb5b outside of the heart field can function to restrict atrial
cell number. Altogether, we conclude that expression of hoxb5b,
which is regulated by RA signaling within the forelimb field, plays
an essential and cell-nonautonomous role in restricting the pro-
duction of atrial cardiomyocytes.
DISCUSSION
Synthesizing our data, we propose a model in which interaction
between the forelimb field and the heart field acts to restrict the
Figure 4. Altered Expression of gata4 and tbx5 in Embryos Deficient
in RA Signaling
(A–D) Expression at the 8 somite stage of gata4 and ntl in WT, BMS-treated,
DEAB-treated, and RO-treated embryos; dorsal views, anterior to the top.
When RA signaling is reduced, the total extent of gata4 expression is longer
(blue arrows). This shift in gata4 expression is most prominent posterior to
the notochord tip (black arrow).
(E–H) Expression of tbx5 in WT, BMS-treated, DEAB-treated, and RO-treated
embryos at the 12 somite stage; lateral views, anterior to the left. (E) In WT em-
bryos at this stage, the total extent of tbx5 expression (yellow outline) is divided
into two comparably sized populations; a black arrow indicates the separation
point. (F–H) When RA signaling is reduced, the separation between popula-
tions is less evident.
Figure 5. Mosaic Analysis Demonstrates a Cell-Autonomous Re-
quirement for RA Signaling during Forelimb Formation
(A–F) Experimental design for mosaic analysis. (A) Donor embryos were in-
jectedwith fluorescein dextran at the one-cell stage. (B andC) At sphere stage,
blastomeres from WT, Tg(hsp70:dnRARa), or BMS-treated donor embryos
were transplanted into the margin of a WT host embryo. (D) At 48 hpf, progeny
of donor-derived cells (arrows) were detected in the heart and fin by anti-fluo-
rescein immunohistochemistry. (E) Mosaic embryo containing donor-derived
cardiomyocytes. (F) Mosaic embryo containing donor-derived cells in pectoral
fin. Only LPM-derived fin cartilage cells (yellow arrows), and not fin ectoderm
(black arrow) or somite-derived fin muscle (Haines and Currie, 2001; Neyt
et al., 2000), were scored as fin.
(G and H) Frequency of heart and fin contributions from heat-shocked
Tg(hsp70:dnRARa), non-heat-shocked Tg(hsp70:dnRARa), WT, or BMS-
treated donor-derived cells. Percentages reflect the number of mosaic em-
bryos exhibiting donor-derived fin mesenchyme (F), atrial (A), or ventricular
(V) cardiomyocytes relative to the total number of transplantation (TT) experi-
ments. Asterisks indicate statistically significant differences fromWT (p <0.05).
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are juxtaposed during early stages of LPM development, and RA
signaling acts cell-autonomously within the forelimb field to in-
duce formation of FPs and expression of RA-responsive genes,
including hoxb5b (Figure 7N). These effects of RA signaling indi-
rectly result in repression of both AP and VP formation within the
heart field, and, in embryos deficient in RA signaling, the ex-
panded AP and VP populations occupy the space created by
the loss of the forelimb field (Figure 7O). Hoxb5b plays a key
role in the restriction of CP formation; although Hoxb5b is not es-
sential for forelimb formation, it is required to limit atrial cell num-
ber through a cell-nonautonomous mechanism (Figure 7P).
Thus, we conclude that communication from the forelimb field,
mediated at least in part by genes downstream of Hoxb5b,
instructs the heart field to limit production of atrial cardiomyo-
cytes, and we speculate that an independent pathway down-
stream of RA signaling plays a similar role in limiting ventricular
cell number.
Our studies offer insight into themechanisms by which RA sig-
naling both promotes forelimb development and restricts heart
size. The direct impact of RA signaling on the forelimb appears
relatively straightforward: RA signaling promotes FP formation
in the forelimb field. This role is consistent with prior work in ze-
brafish and mouse suggesting that RA produced by the paraxial
Figure 6. hoxb5b Morphants Display an Increased Number of Atrial Cardiomyocytes
(A) MOs targeting the donor site of the single intron in either hoxb5a or hoxb5b efficiently abrogate splicing of the respective transcript without affecting the other
transcript. Larger bands in lanes 2 and 4 represent the retained introns of hoxb5a and hoxb5b, respectively.
(B–E, G, and H) hoxb5amorphants have no evident morphological defects, and hoxb5bmorphants exhibit enlarged hearts, pericardial edema, and overtly normal
pectoral fins. Lateral views, anterior to the left, 48 hpf, with higher magnification of pectoral fin outlined in (E), (G), and (H). (F) Genomic intron-exon structure is
completely conserved and nucleotide sequences are highly conserved in the locations that we targeted with anti-hoxb5b and anti-hoxb5a MOs. Uppercase
letters designate first exon sequence, and lowercase letters are intronic sequence. Underline indicates the respective MO target sequences. Asterisks indicate
sequence differences.
(I–R) hoxb5b morphants display an increased number of atrial cardiomyocytes and a normal number of ventricular cardiomyocytes. Views and graphs are as
presented in Figure 1. Error bars represent SD.
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Hoxb5b Restricts Atrial Cell NumberFigure 7. Hoxb5b Acts Nonautonomously to Restrict Atrial Cell
Number
(A–D) Experimental design for transplantation of WT donor cells into morphant
host embryos. (A)WT donor embryos carrying Tg(cmlc2:DsRed2-nuc)were in-
jected with fluorescein dextran at the one-cell stage. (B andC) At sphere stage,
donor blastomeres were transplanted into the margin of hoxb5a or hoxb5b
morphant host embryos. (D) At 48 hpf, cardiomyocyte progeny of donor-
derived cells (arrows) were detected on the basis of their nuclear DsRed local-
ization. Fixation destroys the fluorescence of the fluorescein dextran lineage
tracer, allowing for clean visualization of Amhc (green).
(E) Example of donor cells (arrows) contributing to both the atrium and the
ventricle in a hoxb5a morphant host.
(F) Example of donor cells (arrows) contributing to the atrium in a hoxb5b
morphant host.
(G) Frequency of donor cell contributions to each cardiac chamber in hoxb5a
and hoxb5b morphant hosts.
(H–K) Experimental design for transplantation of hoxb5b morphant or mRNA-
injected donor cells into morphant host embryos. (H) WT donor embryos were
injected with hoxb5b MO or hyperactive hoxb5b mRNA along with fluorescein
dextran at the one-cell stage. (I and J) At sphere stage, donor blastomeres
were transplanted into the margin of hoxb5b morphant host embryos carrying
the transgene Tg(cmlc2:DsRed2-nuc). (K) At 48 hpf, we selected host embryos
in which donor-derived cells contributed to anterior mesoderm lineages other
than the heart and counted thenumber of cardiomyocytes in eachof these hosts.
(L and M) Donor-derived cells expressing hyperactive hoxb5b nonautono-
mously reduce the number of atrial cells in hoxb5bmorphant embryos. Aster-
isks represent statistically significant differences between the pair of values
indicated by each bar. Error bars represent SD.
(N–P) Model of interactions between the forelimb field and heart field that re-
strict the number of CPs. (N) RA signaling acts on the forelimb field to promote
formation of FPs (blue) and expression of RA-responsive genes, including
hoxb5b (yellow oval). This indirectly results in production of two hypothesized930 Developmental Cell 15, 923–934, December 9, 2008 ª2008 Elsemesoderm initiates forelimb development and promotes tbx5
expression in the forelimb field, although previous studies did
not demonstrate the cell-autonomy of this role of RA signaling
(Begemann et al., 2001; Capdevila and Izpisua Belmonte,
2001; Gibert et al., 2006; Grandel et al., 2002; Mic et al., 2004;
Robert and Lallemand, 2006). It is unclear what happens to as-
piring FPs when RA signaling is inhibited. CPs and FPs originate
from nearly the same zone of the 40% epiboly embryo (Keegan
et al., 2004), and the anterior-posterior organization of CPs and
FPs emerges during or shortly after gastrulation as the LPM
forms. In RA signaling-deficient embryos, the posterior exten-
sion of CPs into the region normally occupied by FPs does not
represent a canonical anterior-posterior transformation, since
FPs do not seem to be transformed into CPs. Instead, we envi-
sion that CPs could come to occupy a more posterior position
in the LPM by passively filling the FP void, which may be why
we do not see a major posterior displacement of APs in hoxb5b
morphants. Perhaps the aspiring FPs transform into another,
nonmyocardial lineage, although we have not discerned in-
creases in other cell types, including the endocardium (J.S.W.
and D.Y., unpublished data), in RA signaling-deficient embryos,
consistent with our previous analysis of the endocardial lineage
in BMS-treated embryos (Keegan et al., 2005). Alternatively, FPs
may simply fail to thrive without early receipt of RA signaling; we
have not found evidence of decreased proliferation or cell death
within the forelimb field of RA signaling-deficient embryos (Table
S7), but a gradual loss of cells would be difficult to detect.
In contrast to the direct role of RA within the forelimb field, the
indirect impact of RA signaling on the heart field relies on the ef-
fects of RA-responsive genes, like hoxb5b, that are expressed in
the forelimb field. The pectoral fins appear intact in hoxb5bmor-
phants that exhibit a surplus of atrial cells, again emphasizing
that the forelimb field is not likely to be the source of extra car-
diac cells in this scenario. Additional CPsmay form via fate trans-
formation of a yet unidentified lineage or via increased prolifera-
tion of CPs. The latter model is particularly appealing to consider
for the origin of extra atrial cells, since our 40%epiboly fatemaps
suggest that RA signaling limits the number of cardiomyocytes
produced by individual APs (Figure 1O). We have not been
able to detect differences in proliferation within the heart fields
of RA signaling-deficient embryos through examination of phos-
pho-histone H3 modification or BrdU incorporation (Table S7;
J.S.W. andD.Y., unpublished data), but these negative data can-
not rule out a modest or gradual impact on CP cell cycle length.
Alternatively, the emergence of additional CPs may reflect utili-
zation of otherwise dormant developmental potential that re-
sides within the heart field.
Our data indicate that RA acts via separable mechanisms to
limit the numbers of both ventricular and atrial cardiomyocytes.
Several aspects of our conclusions are consistent with previous
studies in amniotes. Our observation of a posterior extension of
the heart field in zebrafish deficient in RA signaling is reminiscent
of the posterior extension of the SHF in mice lacking Raldh2
repressive signals that limit formation of (1) APs (green) and (2) VPs (red). (O) In
the absence of RA signaling, the expanded AP and VP populations occupy the
space created by the loss of FPs. (P)Without hoxb5b, hypothesized to regulate
repressive signal 1, FPs are intact and still restrict VP formation, but the AP
population is expanded.vier Inc.
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maps at the 8 somite stage (Figures 3F–3I) are comparable to
chick fate maps demonstrating that reduced RA signaling causes
aposterior expansionof VPs into territory normally containingAPs
(Hochgreb et al., 2003). In the chick embryo, this expansion is
thought to be at the expense of atrial progenitors, although a
tradeoff with noncardiac lineages remains a possibility (Hochgreb
et al., 2003).
Despite similarities in the roles of RA across species, our data
do not support amodel in which RA signaling is necessary to par-
tition the heart bypromoting formation of atrial cardiomyocytes at
the expense of ventricular cardiomyocytes, as suggested by pre-
vious analyses of amniotes (Hochgreb et al., 2003; Simoes-Costa
et al., 2005; Xavier-Neto et al., 1999, 2001; Yutzey and Kirby,
2002; Yutzey et al., 1994). It is clear from our studies in zebrafish
that loss of RA signaling increases atrial cell number. Further-
more, although reduced RA signaling causes increased ventricu-
lar cell number in zebrafish, this increasedoesnot occur at theex-
pense of the atrium. It is interesting to note that the excess SHF
progenitors in Raldh2 mutant mice fail to differentiate normally
(Ryckebusch et al., 2008). Therefore, we speculate that RA may
play similar roles in fish and amniotes at early stages, during re-
striction of progenitor specification, while also playing different
roles during later steps of differentiation and morphogenesis
(Chen et al., 1998, 2002; Kastner et al., 1997; Niederreither
et al., 1999, 2001). Future studies in amniotes should help to re-
solve the distinctions between roles of RA at different stages.
The proposed role for RA signaling in partitioning the amniote
heart has also led to an evolutionary model that the two-cham-
bered fish heart evolved via subdivision of a single chamber
(Simoes-Costa et al., 2005; Xavier-Neto et al., 2001; Yutzey
and Kirby, 2002). However, it has also been proposed that the
atrium and ventricle arose from independent evolutionary origins
(Fishman and Chien, 1997). Our data regarding the independent
regulation of atrial and ventricular lineages in zebrafish lend sup-
port to the latter model, in which atria and ventricles arose inde-
pendently, rather than as RA-mediated subdivisions of a single
field (Simoes-Costa et al., 2005; Xavier-Neto et al., 2001; Yutzey
and Kirby, 2002). Our data therefore suggest that RA signaling
does not seem to be an ancestral, conserved mechanism for
partitioning the heart field into AP and VP populations.
Our demonstration that hoxb5b acts downstreamof RA signal-
ing to restrict cardiac cell number suggests that the effects of RA
on the heart field are mediated indirectly via genes expressed
elsewhere, although this does not exclude the possibility that
RA signaling may also have additional roles within the heart field.
We favor the interpretation that hoxb5b regulates heart field size
from its site of expression in the forelimb field, but we cannot rule
out that it influences the heart via its expression in the neural tube.
However, numerous other hox genes, whichmay function redun-
dantly with hoxb5b, are expressed together with hoxb5b in the
ectoderm (Prince et al., 1998a, 1998b), while we have yet to
find another hox genewith similar expression in the forelimb field.
We suspect that the nonautonomous effect of hoxb5b on the
heart field involves downstream transcriptional targets that allow
the forelimb field to communicate with the adjacent heart field.
One possibility is that this communication occurs through the
control of a morphogen gradient, as has been shown for Hox
control of organ size in Drosophila (Crickmore and Mann, 2006,Develop2007). The specific impact of hoxb5b function on atrial, but not
ventricular, cell numbers in zebrafish supports a model in which
RA signaling limits atrial and ventricular cell numbers through in-
dependent downstream pathways. Identification of the relevant
targets ofHoxb5b and elucidation of the pathway limiting ventric-
ular cell number will both be important future endeavors.
It is important to consider whether the role of aHox gene in de-
limiting the heart field may be conserved in amniotes. Although
mouseHoxb5mutants display homeotic defects in vertebral pat-
terning and a shift in position of the shoulder girdle, they do not
appear to exhibit heart defects (McIntyre et al., 2007; Rancourt
et al., 1995). Perhaps subtle cardiac defects are indeed present
in Hoxb5 mutants; addition of extra atrial cells might not be im-
mediately obvious or lethal. Alternatively, other mouse Hox
genes may be contributing to the role played by zebrafish
hoxb5b. Multiple Hox genes are expressed in or near the amniote
heart field (Ryckebusch et al., 2008; Searcy and Yutzey, 1998),
and the mouseHoxa3mutant has been reported to have defects
in cardiac development (Chisaka and Capecchi, 1991; Lo and
Frasch, 2003). Hoxa3 mutants display a number of intriguing
phenotypes that could be related to alteration of cardiac cell
number, including atrial hypertrophy and enlargement of the
great veins, as well as other phenotypes such as patent ductus
arteriosus, stenosis of the aortic valve, and improperly formed
pulmonary valves. Although these defects have been attributed
to problems with neural crest formation (Chisaka and Capecchi,
1991; Lo and Frasch, 2003), it is tempting to speculate that
Hoxa3 could also influence the heart fields.
Overall, our data provide evidence for an unexpected mecha-
nism of interaction between the forelimb and heart fields during
their development. Despite the eventual distance between the
heart and the forelimbs, the juxtaposition of their respective organ
fields at early stages has a potent effect on the restriction of heart
size. Although the precise spatial relationship between the heart
and forelimb fields in amniotes is not yet clear, it is likely that
they are juxtaposed as they are in zebrafish (Wilson, 1998). The in-
teractionbetweenheart and forelimbfields isparticularlygermane
to the greater than 100 heritable congenital syndromes that fea-
ture both heart and forelimb defects (Wilson, 1998). Only a few
of these heart-hand syndromes have been linked to their causa-
tive genes; one notable example is Holt-Oram syndrome, which
is caused by mutation of Tbx5 (Basson et al., 1997; Li et al.,
1997). Since Tbx5 is expressed in both the heart and forelimb
fields, it is thought to autonomously affect both tissues. Our dem-
onstration that genes in the forelimb field can influence the heart
field predicts an alternative, nonautonomous mechanism for the
etiologies of heart-hand syndromes: initial defects in forelimb de-
velopment may indirectly impact heart development. Given this
interaction, we speculate that there may be reciprocal influences
of the heart field on the forelimbfield. Altogether, the identification
of the restriction of heart field potential by the forelimb field sug-
gests a general mechanism by which communication between
adjacent organ fields contributes to the regulation of organ size.
EXPERIMENTAL PROCEDURES
Immunofluorescence and Cell Counting
Tg(cmlc2:DsRed2-nuc)f2 embryos (Mably et al., 2003) were fixed at 48 hpf with
1% formaldehyde in PBS. Embryos were stained with the anti-Amhcmental Cell 15, 923–934, December 9, 2008 ª2008 Elsevier Inc. 931
Developmental Cell
Hoxb5b Restricts Atrial Cell Numbermonoclonal antibody S46 (Stainier and Fishman, 1992; gift of F. Stockdale),
and S46 was detected using a goat anti-mouse IgG1 secondary antibody con-
jugated to FITC (Southern Biotechnology Associates). To determine the num-
ber of cells in each chamber, embryos were gently flattened under a coverslip,
and the fluorescent nuclei in each chamber were counted.
In Situ Hybridization
In situ hybridization was performed as described byOxtoby and Jowett (1993).
All probes used were previously described, with the exceptions of retd
(IMAGE Clone ID - IRAKp961D08178Q2), hoxb5a (IMAGE Clone ID - IMAG
p998E1515251Q1), and hoxb5b (IMAGEClone ID - IRALp962P2160Q2). Areas
of expression of amhc and vmhcwere measured using ImageJ (http://rsb.info.
nih.gov/ij/index.html).
BMS189453, DEAB, and Ro41-5253 Treatments
For all three antagonists of RA signaling, we employed doses that cause heart,
hindbrain, forelimb, and pharyngeal endoderm phenotypes resembling those
caused by genetic reduction of RA signaling in zebrafish raldh2 mutants (Be-
gemann et al., 2004; Gibert et al., 2006; Keegan et al., 2005; Kopinke et al.,
2006; Maves and Kimmel, 2005). For treatment details, see Supplemental Ex-
perimental Procedures.
Microarrays
We compared gene expression profiles from wild-type, BMS-treated, DEAB-
treated, and RA-treated embryos at tailbud and 8 somite stages using Affyme-
trix zebrafish GeneChips. For further details, see Supplemental Experimental
Procedures.
Fate Mapping
Fate mapping at 40% epiboly was performed as previously described (Keegan
et al., 2004, 2005). Fate mapping at the 8 somite stage was performed as pre-
viously described (Schoenebeck et al., 2007), with slight modifications. See
Supplemental Experimental Procedures for further details.
Morpholino and RNA Injections
The anti-raldh2MO was reported previously (Begemann et al., 2001) and was
injected with an anti-p53 MO to reduce toxicity (Robu et al., 2007). To knock
down hoxb5a or hoxb5b, we injected 25 ng of either anti-hoxb5a MO (50-aat
acgtatgtaccatggctaatat-30) or anti-hoxb5b MO (50-agatgtttataccatggctaa
tgtg-30).
For ectopic expression of hoxb5b, embryos were injected with 30 pg of
vp16-hoxb5b mRNA. This construct was made by fusing the vp16 activation
domain directly to the N terminus of zebrafish hoxb5b. Overexpression of
vp16-hoxb5bmRNAposteriorizes embryos in amanner similar to that reported
for wild-type hoxb5bmRNA (Figure S8; Bruce et al., 2001). We consider vp16-
hoxb5b to be a hyperactive form of hoxb5b, since it appears to be more potent
than wild-type hoxb5b.
Generation of the Tg(hsp70:dnRARa) Transgenic Line
We subcloned a human dominant-negative RARa cassette (hRARD403; pro-
vided by Charles Sagerstro¨m; Damm et al., 1993; Roy and Sagerstro¨m,
2004) behind the zebrafish hsp70 promoter (Halloran et al., 2000) and gener-
ated a stable line of transgenic animals. For further details, see Supplemental
Experimental Procedures.
Mosaic Analysis
To perform mosaic analysis, we used standard techniques to transplant blas-
tomeres at sphere stage (Ho and Kane, 1990). Further details are provided in
Supplemental Experimental Procedures.
Phospho-Histone H3 and Apoptotic Cell Labeling
We used the antibody H6409 (Sigma-Aldrich) to detect phospho-histone H3
and the ApopTag kit (Millipore) for TUNEL staining. Stained cells were de-
tected using an alkaline phosphatase-conjugated secondary antibody and
NBT/BCIP.932 Developmental Cell 15, 923–934, December 9, 2008 ª2008 ElseImaging
Embryos were examined using Zeiss M2Bio and Axioplan microscopes. Pho-
tographs were taken using a Zeiss Axiocam. Zeiss AxioVision 3.0.6 software
and Adobe Photoshop were used to process images.
SUPPLEMENTAL DATA
Supplemental Data include eight figures, seven tables, Supplemental Experi-
mental Procedures, and Supplemental References and can be found with
this article online at http://www.developmentalcell.com/supplemental/S1534-
5807(08)00391-2.
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